China In Vitro Diagnostics (IVD) Market Overview

The Chinese IVD market was valued at USD 5.5 billion in 2023, with a projected CAGR of 6.4% over the next six years. Growth is driven by rising chronic diseases (e.g., diabetes, cancer), an aging population, and increased demand for early diagnosis and disease monitoring.

Key Trends & Drivers:

• Government support: Investments in healthcare infrastructure and preventive care (e.g., Healthy China 2030).

• Pandemic impact: COVID-19 accelerated adoption of rapid testing technologies.

• Product commercialization: Easier market entry through co-marketing deals and foreign collaborations (e.g., BGI).

• Technological innovation: Launch of Roche’s China TIC in 2023 highlights local R&D focus.

Market Segmentation Highlights:

• Product: Reagents dominated with 66% share, followed by instruments.

• Technology: Immunoassays led with 32%, while coagulation testing is growing rapidly.

• Application: Infectious diseases accounted for 36% of the market, with growing demand for drug testing.

• End Use: Hospitals held a 43% share, while home-care diagnostics are expanding due to population aging.

Challenges: Stringent regulations and limited reimbursement systems may temper growth despite strong market potential.

 

Test Location Insights – China IVD Market (2023)

???? Point-of-Care (POC) Diagnostics

• Market Share (2023): 21.76% of total IVD revenue.

• Growth Drivers:

  • Rising need for fast, bedside diagnostics.

  • Enables quicker clinical decisions due to proximity to healthcare professionals.

  • Adoption by pharmacists and pharmacies for rapid infectious disease testing.

• Innovation Focus:

  • Compact, portable, and user-friendly instruments.

  • Integration into non-laboratory settings.

???? Home-Care Diagnostics

• Trend Catalysts:

  • COVID-19 pandemic.

  • Aging population and rising chronic disease burden.

• Significance:

  • Key in curbing SARS-CoV-2 spread.

  • Governments actively supporting affordable and accessible home testing.

---

???? Key Company Insights & Competitive Landscape

???? Major Players in China’s IVD Market

• Multinationals:

  • Abbott

  • bioMérieux SA

  • Thermo Fisher Scientific Inc.

  • Bio-Rad Laboratories, Inc.

  • Danaher Corporation

  • Siemens Healthcare GmbH

  • Sysmex Corporation

• China-Based Leaders:

  • Mindray Medical International Limited

  • Shanghai Kehua Bio-Engineering Co. Ltd.

  • Maccura Biotechnology

???? Strategic Developments

• Growth Strategies:

  • Strategic partnerships, M&A, frequent product launches.

  • Emphasis on expanding geographic presence and assay/test kit development.

• Market Investment Example:

  • In January 2022, a leading firm announced a USD 20 million investment to expand its Shanghai manufacturing center.

    • Focus: Increase capacity for liquid chromatography and mass spectrometry products.

 

Report Attribute	Details
Market Size Value (2024)	USD 5.7 billion
Revenue Forecast (2030)	USD 8.4 billion
Growth Rate (CAGR)	6.4% (2024 – 2030)
Actual Data	2018 – 2023
Forecast Period	2024 – 2030

 

 

China In Vitro Diagnostics Market Report Segmentation

This comprehensive forecast assesses the revenue growth prospects at a country level while offering an in-depth examination of the latest industry trends in each sub-segment across China, spanning from 2018 to 2030. Our analysis is further segmented into key categories including technology, product, application, end-use, and test location.

• Technology Outlook (Revenue, USD Million, 2018 - 2030)

  • Immunoassay

  • Hematology

  • Clinical Chemistry

  • Molecular Diagnostics

  • Coagulation

  • Microbiology

  • Others

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Instruments

  • Reagents

  • Software

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Infectious Diseases

  • Diabetes

  • Oncology

  • Cardiology

  • Nephrology

  • Autoimmune Diseases

  • Drug Testing

  • Other applications

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Laboratories

  • Home-care

  • Others

• Test Location Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Point of care

  • Home-care

  • Others

 

-------------------------------------------------------------------------------------------------------------------------------------------------

 

Let’s Get in Touch

The Research Insights Pvt. Ltd.

???? USA Office
1331 Johnson Dr, Buffalo Grove,
Illinois, Chicago, USA

???? India Office
The Hub, Lane No. 6, Meera Nagar Garden Society,
Meera Nagar, Koregaon Park,
Pune, Maharashtra 411001

???? Contact Numbers
India: +91-89564-46619
USA: +1 312-313-8080

???? WhatsApp: +91-89564-46619
???? Email: [email protected]